Linezolid使用例の臨床的背景とその臨床効果

書誌事項

タイトル別名
  • Clinical features of 15 cases treated with linezolid

この論文をさがす

抄録

We investigated the clinical features of 15 cases treated with linezolid (LZD). The patients ranged in age from 0 to 80 years old (mean: 66 years old). Fifteen strains were isolated as pathogens: 11 strains of methicillin-resistant Staphylococcus aureus (MRSA), 3 strains of methicillin-resistant Staphylococcus epidermidis (MRSE), and 1 strain of methicillin-sensitive Staphylococcus aureus (MSSA). The clinical diagnosis was sepsis in 4 cases, infective arthritis in 4, pneumonia in 2, infective endocarditis in 2, osteomyelitis in 2, deep soft tissue and skin infections in 2, mediastinitis in 1, and meningitis in 1 case. The reasons for LZD use were resistance to previous treatment in 10 cases, renal dysfunction in 5, and intolerance to glycopeptides in 4 cases. As for the adverse effects of LZD, anemia in 4 cases, thrombocytepenia in 3, and liver damage in 1 case were recognized. These results suggest that LZD is effective for the complicated infections caused by Grampositive cocci, such as MRSA or methicillin-resistant coagulase negative Staphylococci (MRCNS), and is better tolerance. However, LZD should be given to carefully selected patients, in order to prevent the appearance of LZD-resistant bacteria

収録刊行物

参考文献 (9)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ